Current status of pulmonary metastasectomy from primary epithelial tumors

Tokujiro Yano, Fumihiro Shoji, Yoshihiko Maehara

Research output: Contribution to journalReview article

34 Citations (Scopus)

Abstract

The resection of pulmonary metastases can prolong the survival of selected patients and its therapeutic value is now accepted. The criteria for eligibility have also evolved. We reviewed the recent literature on pulmonary metastasectomy for various epithelial primary tumors and tried to establish better prognostic indicators for its surgical application. In addition to the welldefined requisites for pulmonary metastasectomy, other requirements include the absence of mediastinal lymph node involvement, a limited number of pulmonary metastatic lesions, a long disease-free interval, small metastasis, and no elevation of tumor markers, although the clinical importance of each factor varies among the primary tumors. On the other hand, with the development of video-assisted thoracoscopic surgery (VATS) and advances in thoracic imaging technology, VATS metastasectomy might become an accepted treatment for metastatic nodules located in the periphery of the lung, which can be easily removed by a wedge resection. Repeat surgery is also possible during follow-up after VATS.

Original languageEnglish
Pages (from-to)91-97
Number of pages7
JournalSurgery today
Volume39
Issue number2
DOIs
Publication statusPublished - Feb 1 2009

Fingerprint

Metastasectomy
Video-Assisted Thoracic Surgery
Lung
Neoplasms
Neoplasm Metastasis
Tumor Biomarkers
Reoperation
Thorax
Lymph Nodes
Technology
Survival
Therapeutics

All Science Journal Classification (ASJC) codes

  • Surgery

Cite this

Current status of pulmonary metastasectomy from primary epithelial tumors. / Yano, Tokujiro; Shoji, Fumihiro; Maehara, Yoshihiko.

In: Surgery today, Vol. 39, No. 2, 01.02.2009, p. 91-97.

Research output: Contribution to journalReview article

Yano, Tokujiro ; Shoji, Fumihiro ; Maehara, Yoshihiko. / Current status of pulmonary metastasectomy from primary epithelial tumors. In: Surgery today. 2009 ; Vol. 39, No. 2. pp. 91-97.
@article{d5ba4da493454404aeaa6566e43e5222,
title = "Current status of pulmonary metastasectomy from primary epithelial tumors",
abstract = "The resection of pulmonary metastases can prolong the survival of selected patients and its therapeutic value is now accepted. The criteria for eligibility have also evolved. We reviewed the recent literature on pulmonary metastasectomy for various epithelial primary tumors and tried to establish better prognostic indicators for its surgical application. In addition to the welldefined requisites for pulmonary metastasectomy, other requirements include the absence of mediastinal lymph node involvement, a limited number of pulmonary metastatic lesions, a long disease-free interval, small metastasis, and no elevation of tumor markers, although the clinical importance of each factor varies among the primary tumors. On the other hand, with the development of video-assisted thoracoscopic surgery (VATS) and advances in thoracic imaging technology, VATS metastasectomy might become an accepted treatment for metastatic nodules located in the periphery of the lung, which can be easily removed by a wedge resection. Repeat surgery is also possible during follow-up after VATS.",
author = "Tokujiro Yano and Fumihiro Shoji and Yoshihiko Maehara",
year = "2009",
month = "2",
day = "1",
doi = "10.1007/s00595-008-3820-9",
language = "English",
volume = "39",
pages = "91--97",
journal = "Surgery Today",
issn = "0941-1291",
publisher = "Springer Japan",
number = "2",

}

TY - JOUR

T1 - Current status of pulmonary metastasectomy from primary epithelial tumors

AU - Yano, Tokujiro

AU - Shoji, Fumihiro

AU - Maehara, Yoshihiko

PY - 2009/2/1

Y1 - 2009/2/1

N2 - The resection of pulmonary metastases can prolong the survival of selected patients and its therapeutic value is now accepted. The criteria for eligibility have also evolved. We reviewed the recent literature on pulmonary metastasectomy for various epithelial primary tumors and tried to establish better prognostic indicators for its surgical application. In addition to the welldefined requisites for pulmonary metastasectomy, other requirements include the absence of mediastinal lymph node involvement, a limited number of pulmonary metastatic lesions, a long disease-free interval, small metastasis, and no elevation of tumor markers, although the clinical importance of each factor varies among the primary tumors. On the other hand, with the development of video-assisted thoracoscopic surgery (VATS) and advances in thoracic imaging technology, VATS metastasectomy might become an accepted treatment for metastatic nodules located in the periphery of the lung, which can be easily removed by a wedge resection. Repeat surgery is also possible during follow-up after VATS.

AB - The resection of pulmonary metastases can prolong the survival of selected patients and its therapeutic value is now accepted. The criteria for eligibility have also evolved. We reviewed the recent literature on pulmonary metastasectomy for various epithelial primary tumors and tried to establish better prognostic indicators for its surgical application. In addition to the welldefined requisites for pulmonary metastasectomy, other requirements include the absence of mediastinal lymph node involvement, a limited number of pulmonary metastatic lesions, a long disease-free interval, small metastasis, and no elevation of tumor markers, although the clinical importance of each factor varies among the primary tumors. On the other hand, with the development of video-assisted thoracoscopic surgery (VATS) and advances in thoracic imaging technology, VATS metastasectomy might become an accepted treatment for metastatic nodules located in the periphery of the lung, which can be easily removed by a wedge resection. Repeat surgery is also possible during follow-up after VATS.

UR - http://www.scopus.com/inward/record.url?scp=59849119175&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=59849119175&partnerID=8YFLogxK

U2 - 10.1007/s00595-008-3820-9

DO - 10.1007/s00595-008-3820-9

M3 - Review article

VL - 39

SP - 91

EP - 97

JO - Surgery Today

JF - Surgery Today

SN - 0941-1291

IS - 2

ER -